Advanced Search

 

Study ID Status Title Patient Level Data
111626 Completed A trial to evaluate the immunogenicity of accelerated primary vaccination with monovalent A/Indonesia/5/05 (H5N1) vaccine antigen in association with AS03 adjuvant in adults aged 18-64. Study Listed on ClinicalStudyDataRequest.com
111631 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
111634 Completed Primary and booster vaccination course in human immunodeficiency virus (HIV) infected infants, HIV exposed uninfected infants and unexposed uninfected infants receiving the pneumococcal vaccine GSK 1024850A.
111635 Completed Clinical study in children, 6 months to 3 years of age, to assess the immunogenicity and safety of two dose levels of thimerosal-free Fluviral® vaccine, using a licensed influenza virus vaccine, Vaxigrip® as the control Study Listed on ClinicalStudyDataRequest.com
111645 Completed A Phase 1/2, Open-Label, Multicenter Study of GSK1363089Gin Adult Subjects with Hepatocellular Carcinoma
111649 Completed A randomised, double-blind study in healthy volunteers to compare the properties and characteristics of an investigational formulation of lamotrigine with placebo Study Listed on ClinicalStudyDataRequest.com
111651 Completed A study to evaluate GSK Biologicals’ candidate formulations of pneumococcal vaccines (GSK2189242A) in young adults. Study Listed on ClinicalStudyDataRequest.com
111652 Completed A study to evaluate GSK Biologicals’ candidate formulations of pneumococcal vaccines (GSK2189241A) in elderly subjects. Study Listed on ClinicalStudyDataRequest.com
111654 Completed Non-inferiority of a commercial lot of the pneumococcal vaccine GSK1024850A compared to a clinical lot. Study Listed on ClinicalStudyDataRequest.com
111662 Completed A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage Parkinson's Disease
111664 Completed Reactogenicity and safety of two doses of GSK Biologicals’ oral live attenuated human rotavirus vaccine, Rotarix™ when administered in Sri Lankan infants aged at least 6 weeks at the time of first vaccination.
111670 Completed Long-term antibody persistence of GSK Biologicals' MenACWY-TT vaccine versus Menactra® in healthy adolescents/adults aged 10-25 years and booster response to MenACWY-TT vaccine administered at 5 years post-primary vaccination
111679 Completed Efficacy and safety of HIV Vaccine 732462 in ART-naïve HIV-1 infected persons
111680 Completed An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Albiglutide in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
111681 Completed An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Warfarin When Coadministered With Albiglutide in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
111684 Completed Analysis of expression of antigens in bone marrow samples from volunteering donors.
111687 Completed An Open-Label Study to Investigate the Pharmacodynamics of a Repeat Dose Regimen of Bevacizumab (10 mg/kg q2w) and Escalating Repeat Doses of Pazopanib in Renal Cell Carcinoma
111700 Completed Safety of GlaxoSmithKline Biologicals’ oral live attenuated human rotavirus vaccine, Rotarix™ or Rotarix™ liquid formulation (oral suspension or prefilled syringe) when administered according to the prescribing information in Korea
111709 Completed Study in healthy children of GSK Biologicals’ DTPa-IPV/Hib-MenC-TT vaccine, GSK2197870A, co-administered with Prevenar™ as a three-dose primary vaccination course in infancy followed by a booster dose of Menitorix™ at 12 months of age Study Listed on ClinicalStudyDataRequest.com
111712 Completed Safety study of GSK Biologicals’ human papillomavirus vaccine (GSK-580299) in healthy female subjects. Study Listed on ClinicalStudyDataRequest.com
111714 Terminated Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in association with chemotherapy in patients with unresectable and progressive metastatic cutaneous melanoma
111716 Completed A Phase I, Open-label, Single Sequence, Crossover Study Evaluating the Safety and the Pharmacokinetics of Lopinavir/Ritonavir and Eltrombopag Given Alone and when Co-administered in Healthy Adult Subjects.
111718 Completed A randomized-open-label-five-period-balanced-crossover study to evaluate the relative bioavailability of an eltrombopag PfOS formulation relative to the 25 mg tablet formulation and to evaluate administration of the PfOS formulation with and separated 2 hours from a high calcium meal in HV
111720 Completed Quality of Life(QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
111726 Completed Analysis of the incidence of expression of tumor antigens and tumor marker in cancer tissue from Asian patients with hepatocellular carcinoma and evaluation of prognostic significance of these tumor antigens.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.